Micko22 - the cost of treatment to the pt is generally a far cry form the sales revenue of OSL, or any medical device maker.
The May20 prese estimating $25k per device is IMO the cost to the pt, not the amount OSL would receive. Happy to be corrected is there is any solid data showing that.
Of course if that were OSL revenue then that would suggest only 3 sales in 6 months. Therefore I suggest this is not the amount OSL sales the product for.
- Forums
- ASX - By Stock
- Ann: First Austria-based treatments utilising the OncoSil device
OSL
oncosil medical ltd
Add to My Watchlist
6.84%
!
$1.02

Micko22 - the cost of treatment to the pt is generally a far cry...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
0.065(6.84%) |
Mkt cap ! $14.43M |
Open | High | Low | Value | Volume |
$1.00 | $1.03 | 96.0¢ | $23.22K | 23.59K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15628 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 1042 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15628 | 0.950 |
2 | 1349 | 0.940 |
1 | 627 | 0.920 |
1 | 23 | 0.910 |
1 | 20000 | 0.905 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 1042 | 1 |
1.030 | 27 | 1 |
1.050 | 25000 | 1 |
1.075 | 1879 | 1 |
1.080 | 48 | 1 |
Last trade - 14.07pm 18/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online